Cancer Letters Volume 468 to 495

Journal Overview: Cancer Letters

Cancer Letters is an esteemed international journal dedicated to the field of oncology, with a primary focus on basic and translational cancer research. This journal serves as a platform for the publication of full-length research articles and Mini Reviews, providing a comprehensive view of the latest developments in the understanding and treatment of cancer. In addition to regular issues, Cancer Letters features Special Issues that delve into specific topical areas within the field of cancer research.

The scope of Cancer Letters encompasses a wide range of topics within basic and translational oncology, including, but not limited to:

1. Molecular Genetics and Cell Biology of Cancer: Exploration of the genetic and cellular mechanisms underlying cancer development and progression.
2. Radiation Biology: Research into the effects of radiation on cancer cells, as well as the development of novel radiation therapies.
3. Molecular Pathology: Investigations into the molecular basis of cancer pathology and the development of diagnostic tools.
4. Hormones and Cancer: Studies exploring the role of hormones in cancer development and potential hormone-based therapies.
5. Viral Oncology: Research focusing on viruses and their contributions to cancer, as well as the development of virus-related therapies.
6. Metastasis: Understanding the mechanisms of cancer metastasis, which is critical for improving treatment strategies.
7. Chemoprevention: Research into preventive measures and chemopreventive agents aimed at reducing cancer risk.

Cancer Letters places particular emphasis on experimental therapeutics, including targeted therapies designed for personalized cancer medicine. This encompasses the development and evaluation of treatments tailored to individual patients, as well as metronomic chemotherapy approaches.

The journal publishes articles in the English language, ensuring accessibility to a global readership of researchers, clinicians, and scientists working in the field of oncology. Cancer Letters strives to contribute to the advancement of cancer research and the development of innovative therapies for the benefit of cancer patients worldwide.

Volume 468: Pages 1-102 (1 January 2020)

Volume 469: Pages 1-528 (28 January 2020)

Volume 470: Pages 1-220 (1 February 2020)

Volume 471: Pages 1-146 (28 February 2020)

Volume 472: Pages 1-184 (1 March 2020)

Volume 473: Pages 1-202 (31 March 2020)

Volume 474: Pages 1-168 (1 April 2020)

Volume 475: Pages 1-142 (10 April 2020)

Volume 476: Pages 1-184 (28 April 2020)

Volume 477: Pages 1-156 (1 May 2020)

Volume 478: Pages 1-146 (28 May 2020)

Volume 479: Pages 1-122 (1 June 2020)

Volume 480: Pages 1-56 (28 June 2020)

Volume 481: Pages 1-76 (1 July 2020)

Volume 482: Pages 1-136 (10 July 2020)

Volume 483: Pages 1-136 (28 July 2020)

Volume 484: Pages 1-72 (1 August 2020)

Volume 485: Pages 1-66 (10 August 2020)

Volume 486: Pages 1-72 (28 August 2020)

Volume 487: Pages 1-84 (1 September 2020)

Volume 488: Pages 1-62 (28 September 2020)

Volume 489: Pages 1-182 (1 October 2020)

Volume 490: Pages 1-192 (10 October 2020)

Volume 491: Pages 1-180 (28 October 2020)

Volume 492: Pages 1-196 (1 November 2020)

Volume 493: Pages 1-284 (28 November 2020)

Volume 494: Pages 1-142 (1 December 2020)

Volume 495: Pages 1-224 (28 December 2020)